Skip to main content
AMRX logo
AMRX
(NASDAQ)
Amneal Pharmaceuticals, Inc.
$16.66-- (--)
Loading... - Market loading

Amneal Pharmaceuticals (AMRX) Stock Price & Financial Analysis

Amneal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.93 - $16.73
52-Week High$16.73
52-Week Low$7.67
Open$16.00
Volume1.80M
Average Volume (3M)1.82M
Market Cap5.48B
Shares Outstanding328.93M
P/E Ratio (TTM)44.79
Price to Sales (P/S)1.80
Price to Book (P/B)-120.68
EV/EBITDA12.86
Revenue (TTM)3.05B
Net Income (TTM)122.36M
Free Cash Flow (TTM)196.96M
EPS (TTM)$0.38
Profit Margin4.02%
Operating Margin14.11%
50-Day MA$13.51
200-Day MA$12.46
52-Week Change110.49%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Amneal Pharmaceuticals

What is the current stock price for AMRX?

As of the latest trading session, AMRX stock trades at $16.66. The 52-week range is $7.67–$16.73, with a day range of $15.93–$16.73.

What is the P/E ratio for AMRX?

Amneal Pharmaceuticals's trailing P/E ratio is 44.8, meaning investors pay $44.8 for every $1 of annual earnings. Amneal Pharmaceuticals operates in the Healthcare sector.

Does AMRX pay dividends?

Amneal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AMRX?

Based on 7 analysts, the consensus for AMRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AMRX?

Amneal Pharmaceuticals's market capitalization is $5.48B, classifying it as a mid-cap company. Amneal Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.